Almoosa posts broad-based sectoral growth, upbeat about Q3 2025: CEO

Malek Almoosa, CEO of Almoosa Health Group

Almoosa Health Co. witnessed broad-based growth in the performance of various medical subdivisions in Q2 2025, backed by its continued strategic expansion and improvements to its integrated healthcare delivery model, according to CEO Malek Almoosa.

Addressing Argaam during a meeting with analysts and investors, Almoosa underlined that this uptrend was not limited to a specific business area, but rather covered surgery, primary care, rehabilitation, hematology, oncology, neurosciences, and orthopedics.

"This diversification contributed to bolstering the company's overall performance during the three-month period,” he said.

The CEO continued, "July — the first month of Q3 2025 — exhibited strong performance, particularly in the rehabilitation subdivision.”

In the surgery section, utilization rates and patient footfall also increased, having incurred no impact from the seasonality of the summer holidays. “This in turn reinforces expectations for positive results during the third quarter of this year,” Almoosa further stated.

In Q2 2025, inpatient volumes surged by 15.4% to 10,000. Moreover, outpatient visits accelerated by 13.2% to 287,100 in total, he added.

Almoosa Health, according to CEO, remains committed to its expansion plans. Last July, it opened the Nakheel Medical Center in Al-Ahsa, which features 37 clinics across a built-up area of 6,100 square meters.

He added that work is underway at the Aziziyah Medical Center in Al-Khobar and the Salmaniya Medical Center in Al-Ahsa.